Rationale: Among patients with nontuberculous mycobacterial lung disease is a subset of
previously healthy women with a slender body morphotype, often with scoliosis and/or pectus …

Rationale: Mycobacterium abscessus is a significant threat to individuals with cystic fibrosis (CF)
because of innate drug resistance and potential transmission between patients. Recent …

Mycobacterium avium complex (MAC) species constitute most mycobacteria infections in
persons with cystic fibrosis (CF) in the United States, but little is known about their genomic …

Rationale: Mycobacterium abscessus group lung infection is characterized by low cure rates.
Improvement in quality of life may be a reasonable treatment goal. Objectives: The …

Nontuberculous mycobacteria (NTM) pose a threat to individuals with cystic fibrosis (CF) due
to an increased prevalence of pulmonary infections, innate drug resistance of the bacteria, …

Results: CDC received reports of 1,544 cases of malaria with onset of symptoms during
1997 among persons in the United States or one of its territories. This number represents an …

Purpose: PI-88 is a mixture of highly sulfated oligosaccharides that inhibits heparanase, an
extracellular matrix endoglycosidase, and the binding of angiogenic growth factors to …

Diagnosis of Mycobacterium avium complex pulmonary disease (MAC-PD) can be difficult.
A previous study from Japan reported the usefulness of a serodiagnostic test for MAC-PD. …

Purpose Mycobacterium abscessus disease is one of the most difficult mycobacterial infections
to cure, as the bacterium is highly resistant to conventional antibiotics. The purpose of …

The Mycobacterium abscessus group is an increasingly recog-nized cause of antibiotic-resistant
lung infection (1–3). The efficacy of available antibiotics must be optimized. Continuous …